Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #160854 on Biotech Values
mcbio
05/07/13 9:13 PM
#160855 RE: JJM760 #160854
No love for Ariad here on BV? Pretty nice start for Ponatinib, especially in light of the fact that it is a dirty drug, with a bad AE profile and a high discontinuation rate.